[ { "@graph" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#pubinfo" } ] } ], "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#Head" }, { "@graph" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_3393", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#association", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_3393" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "https://identifiers.org/drugbank:DB00998" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "\"Frovatriptan succinate tablets are contraindicated in patients with: Ischemic coronary artery disease (CAD) (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia), or coronary artery vasospasm, including Prinzmetal's angina [see Warnings and Precautions ( 5.1 Wolff-Parkinson-White Syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see Warnings and Precautions ( 5.2 History of stroke, transient ischemic attack (TIA), or history of hemiplegic or basilar migraine because these patients are at a higher risk of stroke [s ee Warnings and Precautions ( 5.4 Peripheral vascular disease [s ee Warnings and Precautions ( 5.5 Ischemic bowel disease [s ee Warnings and Precautions ( 5.5 Uncontrolled hypertension [see Warnings and Precautions ( 5.8 Recent use (i.e., within 24 hours) of another 5-HT 1 [see Drug Interactions ( 7.1 7.2 Hypersensitivity to frovatriptan succinate (angioedema and anaphylaxis seen) [s ee Warnings and Precautions ( 5.9 History of coronary artery disease or coronary artery vasospasm ( 4 Wolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disorders ( 4 History of stroke, transient ischemic attack, or hemiplegic or basilar migraine ( 4 Peripheral vascular disease ( 4 Ischemic bowel disease ( 4 Uncontrolled hypertension ( 4 Recent (within 24 hours) use of treatment with another 5-HT 1 4 Hypersensitivity to frovatriptan succinate tablets (angioedema and anaphylaxis seen) ( 4\"" } ], "https://w3id.org/biolink/vocab/provided_by" : [ { "@id" : "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "https://schema.org/MedicalContraindication" } ] }, { "@id" : "https://identifiers.org/drugbank:DB00998", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] } ], "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ] } ], "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-08-23T18:38:13.760+02:00" } ], "http://purl.org/dc/terms/creator" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ { "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ { "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "cdU6ZiV0jP+1Ptbr+tKIJM91MMjvEPZLvMMLNaPjLDUQ32M06+DVV8x/8IrNgyw3Qd3vMLlJwUpOViSwEtQhqiePf0XpMr1wOMOHq2KmIaXkfTz3RAP9rwyLH4noPzpvu+v05dzEJlnA6lf/NxZXgHLDXDOoy9nl/XGrm1vGQ34=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A" } ] } ], "@id" : "http://purl.org/np/RAnxcUg66oIDxDtse0FG6ZrnNAo2AVWGwp0yqQNfSFA-A#pubinfo" } ]